Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium PK comparison of Easyhaler variants vs Spiriva
NCT04850144Phase 1Completed
- Sponsor
- Orion Corporation
- Start
- Apr 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tiotropium in chronic obstructive pulmonary disease (COPD) and asthma (7 arms), sponsored by Orion Corporation. Primary endpoints: Peak tiotropium concentration in plasma, Area under the concentration-time curve from time zero to 30 minutes and 1 more. Started Apr 2021; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)asthma
Beyond the preview
Go deeper on NCT04850144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04850144.